Ledger.Open graph →

SEC Form D · filed September 6, 2018

OncoResponse Inc

Offering

$40.0M

Sold

$19.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HOUSTON, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Thomas W. Brown · Beverly, MADirector Wesley P. Kubesch · Houston, TXDirector Robert A. Contreras · CHICAGO, ILDirector Andrew Perlman · New York, NYDirector Nathan Jorgensen · Newton, MADirector Divesh C. Makan · San Francisco, CADirector Bryan B. Hinton · South Jordan, UTDirector Matt Bailey · Durham, NCDirector Clifford Stocks · Houston, TXExec · Director Andrew Perlman · Seattle, WADirector Roberto Deponti · None, LuxembourgDirector Nathan Jorgensen · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗